AJG vs REGN · P/E 33, rev $8.76B vs P/E 14, rev $4.29B
Arthur J Gallagher & Co (AJG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Arthur J Gallagher & Co (AJG) is a insurance brokers company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported AJG revenue for 2026-06-30 was $8.76B. Net income was $1.15B. Revenue was up 84.1% from 2026-03-31 to 2026-06-30. AJG currently screens at market cap $52.03B and trailing P/E 32.8.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
AJG currently screens at market cap $52.03B and trailing P/E 32.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the AJG and REGN stock pages for the full models.
Not investment advice.